Small molecule inhibitors of regulators of G protein signaling (rgs) proteins

ACS Medicinal Chemistry Letters

Volumn 3, Issue 2, 2012, Pages 146-150

  Turner, Emma M ^a   Blazer, Levi L ^b   Neubig, Richard R ^b   Husbands, Stephen M ^a  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

GPCR; protein protein interaction; RGS protein; RGS4; thiadiazolidinone

Indexed keywords

CALCIUM; CCG 50014; PROTEIN INHIBITOR; RGS4 PROTEIN INHIBITOR; RGS8 PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CALCIUM MOBILIZATION; DRUG ACTIVITY; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG POTENTIATION; DRUG SCREENING; DRUG SELECTIVITY; DRUG SOLUBILITY; PRIORITY JOURNAL;

RODENTIA;

EID: 84856877986     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml200263y     Document Type: Article

References (26)

1. Hopkins, A. L.; Groom, C. R. The druggable genome Nat. Rev. Drug Discovery 2002, 1, 727-30 (Pubitemid 37361545)
2. Conn, P. J.; Christopoulos, A.; Lindsley, C. W. Allosteric modulators of GPCRs: A novel approach for the treatment of CNS disorders Nat. Rev. Drug Discovery 2009, 8, 41-54
3. Willars, G. B. Mammalian RGS proteins: Multifunctional regulators of cellular signalling Semin. Cell Dev. Biol. 2006, 17, 363-376 (Pubitemid 44066847)
4. Sjögren, B.; Neubig, R. R. Thinking outside of the "RGS Box": New approaches to therapeutic targeting of regulators of G protein signalling Mol. Pharmacol. 2010, 78, 550-557
5. Blazer, L. L.; Neubig, R. R. Small molecule protein-protein interaction inhibitors as CNS therapeutic agents: Current progress and future hurdles Neuropsychopharmacology 2009, 34, 126-141
6. Gold, S. J.; Ni, Y. G.; Dohlman, H. G.; Nestler, E. J. Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain J. Neurosci. 1997, 17, 8024-8037 (Pubitemid 27426238)
7. Sugino, K.; Hempel, C. M.; Miller, M. N.; Hattox, A. M.; Shapiro, P.; Wu, C.; Huang, Z. J.; Nelson, S. B. Molecular taxonomy of major neuronal classes in the adult mouse forebrain Nat. Neurosci. 2006, 9, 99-107 (Pubitemid 43011915)
8. Bansal, G.; Druey, K. M.; Xie, Z. R4 RGS proteins: Regulation of G-protein signaling and beyond Pharmacol. Ther. 2007, 116, 473-495 (Pubitemid 350116944)
9. Wang, Q.; Traynor, J. R. Opioid induced down-regulation of RGS4: Role of ubiquitination and implications for receptor cross-talk J. Biol. Chem. 2011, 286, 7854-7864
10. Wang, Q.; Liu-Chen, L,Y.; Traynor, J. R. Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells J. Biol. Chem. 2009, 284, 18357-18367
11. Tesmer, J. J.; Berman, D. M.; Gilman, A. G.; Sprang, S. R. Structure of RGS4 bound to AlF4 - activated G(i alpha1): Stabilization of the transition state for GTP hydrolysis Cell 1997, 89, 251-261 (Pubitemid 27199897)
12. Roman, D. L.; Blazer, L. L.; Monroy, C. A.; Neubig, R. R. Allosteric inhibition of the regulator of G protein signaling-Galpha protein-protein interaction by CCG-4986 Mol. Pharmacol. 2010, 78, 360-365
13. Roman, D. L.; Talbot, J. N.; Roof, R. A.; Sunahara, R. K.; Traynor, J. R.; Neubig, R. R. Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay Mol. Pharmacol. 2007, 71, 169-175 (Pubitemid 46020986)
14. Blazer, L. L.; Roman, D. L.; Chung, A.; Larsen, M.; Greedy, B. M.; Husbands, S. M.; Neubig, R. Reversible, allosteric, small-molecule inhibitors of Regulator of G Protein Signalling Proteins Mol. Pharmacol. 2010, 78, 524-533
15. Blazer, L. L.; Zhang, H.; Casey, E. M.; Husbands, S. M.; Neubig, R. R. A nanomolar-potency small molecule inhibitor of Regulator of G protein Signaling (RGS) proteins Biochemistry 2011, 50, 3181-3192
16. Blazer, L. L.; Roman, D. L.; Muxlow, M. R.; Neubig, R. R. Use of flow cytometric methods to quantify protein-protein interactions Curr. Protoc. Cytom. 2010, 13, 13.11.1-13.11.15
17. Roman, D. L.; Ota, S.; Neubig, R. R. Polyplexed flow cytometry protein interaction assay: A novel high-throughput screening paradigm for RGS protein inhibitors J. Biomol. Screening 2009, 14, 610-619
18. Slomczyńska, U.; Barany, G. Efficient Synthesis of 1,2,4-Dithiazolidine-3,5-diones (Dithiasuccinoyl-amines) and Observations on Formation of 1,2,4-Thiadiazolidine-3,5-diones by Related Chemistry J. Heterocycl. Chem. 1984, 21, 241-246
19. Martinez, A.; Alonso, M.; Castro, A.; Pérez, C.; Moreno, F. J. First non-ATP competitive glycogen synthase kinase 3b (GSK-3b) inhibitors: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease J. Med. Chem. 2002, 45, 1292-1299 (Pubitemid 34263565)
20. Nasim, S.; Crooks, P. A. N-Chlorosuccinimide is a convenient oxidant for the synthesis of 2,4-disubstituted 1,2,4-thiadiazolidine-3,5-diones Tetrahedron Lett. 2009, 50, 257-259
21. Clark, M. A.; Sethi, P. R.; Lambert, N. A. Active Gαq subunits and M3 acetylcholine receptors promote distinct modes of association of RGS2 with the plasma membrane FEBS Lett. 2007, 581, 764-770 (Pubitemid 46216302)
22. Guzman, M. L.; Li, X.; Corbett, C. A.; Rossi, R. M.; Bushnell, T.; Liesveld, J. L.; Hébert, J.; Young, F.; Jordan, C. T. Rapid and selective death of leukemia stem cells and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine-3,5-dione (TDZD-8) Blood 2007, 110, 4436-4444 (Pubitemid 351377810)
23. Aguilar-Morante, D.; Morales-Garcia, J. A.; Sanz-San Cristobal, M.; Garcia-Cabezas, M. A.; Santos, A.; Perez-Castillo, A. Inhibition of Glioblastoma Growth by the Thiadiazolidinone compound TDZD-8 PLoS ONE 2010, 5, e13879
24. Selenica, M. L.; Jensen, H. S.; Larsen, A. K.; Pederson, M. L.; Helboe, L.; Lotharius, J. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation Br. J. Pharmacol. 2007, 152, 959-979 (Pubitemid 350100498)
25. Rosa, A. O.; Kaster, M. P.; Binfaré, R. W.; Morales, S.; Martín-Aparicio, E.; Navarro-Rico, M. L.; Martinez, A.; Medina, M.; García, A. G.; López, M. G.; Rodrigues, A. L. S. Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2008, 32, 1549-1556
26. i2 selectively potentiates 5-HT1A-mediated antidepressant effects Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 11086-11091